This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yokota, T. Articles by Schlom, J. Search for Related Content PubMed PubMed Citation Articles by Yokota, T. Articles by Schlom, J.

Rapid Tumor Penetration of a Single-Chain Fv and Comparison with Other Immunoglobulin Forms

Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892 [T. Y., D. E. M., J. S.], and Enzon, Inc., Gaithersburg, Maryland 20877 [M. W.]

Single-chain antigen-binding proteins, or sFvs, represent potentially unique molecules for targeted delivery of drugs, toxins, or radionuclides to a tumor site. In previous studies (Cancer Res., 51: 6363–6371, 1991) using a human colon carcinoma xenograft model, it was demonstrated that the sFv has an extremely rapid plasma and whole body clearance, as compared to intact IgG or Ig fragments. One potential consequence of the rapid sFv pharmacokinetic properties was the reduced percentage of injected dose/g of the radiolabeled sFv found in the tumor throughout a range of time points. The present study was designed to define the tumor penetration properties of a radiolabeled sFv in comparison with other Ig forms. ¹²⁵I-labeled sFv, Fab', F(ab')₂, and IgG forms of monoclonal antibody CC49, directed against the human pancarcinoma antigen TAG-72, were used to target the LS-174T human colon carcinoma xenograft in athymic mice. At various time points after systemic Ig administration, quantitative autoradiographic analyses of surgically removed tumors were used to define the rate and degree of penetration of the various Ig forms. These studies revealed that most of the intact IgG delivered to the tumor was concentrated in the region of or immediately adjacent to vessels, while the sFv was more evenly distributed throughout the tumor mass. The distributions of the Fab' and F(ab')₂ fragments showed intermediate penetration in a size-related manner. The sFv demonstrated maximum tumor penetration at 0.5 h postinjection, while the intact IgG reached an equivalent degree of penetration at 48 to 96 h postinjection. These studies thus reveal a greater degree of uptake throughout the tumor for the sFv than would be expected by gross analyses of percentage injected dose/g and demonstrate an extremely rapid tumor penetration of the sFv. These studies should aid in the rational design of potential applications of drug-, toxin-, and radionuclide-conjugated sFvs in cancer therapy.

¹ To whom requests for reprints should be addressed, at Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Building 10, Room 8B07, Bethesda, MD 20892.

Received 1/10/92. Accepted 4/ 6/92.

This article has been cited by other articles:

				A.S. Samuel and R.K. Naz Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development Hum. Reprod., June 1, 2008; 23(6): 1324 - 1337. [Abstract] [Full Text] [PDF]

				A. Khaibullina, B.-S. Jang, H. Sun, N. Le, S. Yu, V. Frenkel, J. A. Carrasquillo, I. Pastan, K. C.P. Li, and C. H. Paik Pulsed High-Intensity Focused Ultrasound Enhances Uptake of Radiolabeled Monoclonal Antibody to Human Epidermoid Tumor in Nude Mice J. Nucl. Med., February 1, 2008; 49(2): 295 - 302. [Abstract] [Full Text] [PDF]

				S. A. Hammond, R. Lutterbuese, S. Roff, P. Lutterbuese, B. Schlereth, E. Bruckheimer, M. S. Kinch, S. Coats, P. A. Baeuerle, P. Kufer, et al. Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct Cancer Res., April 15, 2007; 67(8): 3927 - 3935. [Abstract] [Full Text] [PDF]

				J. E. Hansen, L. K. Fischer, G. Chan, S. S. Chang, S. W. Baldwin, R. J. Aragon, J. J. Carter, M. Lilly, R. N. Nishimura, R. H. Weisbart, et al. Antibody-Mediated p53 Protein Therapy Prevents Liver Metastasis In vivo Cancer Res., February 15, 2007; 67(4): 1769 - 1774. [Abstract] [Full Text] [PDF]

				M. S. Dennis, H. Jin, D. Dugger, R. Yang, L. McFarland, A. Ogasawara, S. Williams, M. J. Cole, S. Ross, and R. Schwall Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent Cancer Res., January 1, 2007; 67(1): 254 - 261. [Abstract] [Full Text] [PDF]

				S. Kubetzko, E. Balic, R. Waibel, U. Zangemeister-Wittke, and A. Pluckthun PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5: EFFECTS ON TUMOR TARGETING J. Biol. Chem., November 17, 2006; 281(46): 35186 - 35201. [Abstract] [Full Text] [PDF]

				A. Orlova, M. Magnusson, T. L.J. Eriksson, M. Nilsson, B. Larsson, I. Hoiden-Guthenberg, C. Widstrom, J. Carlsson, V. Tolmachev, S. Stahl, et al. Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule. Cancer Res., April 15, 2006; 66(8): 4339 - 4348. [Abstract] [Full Text] [PDF]

				G. P. Adams, M.-S. Tai, J. E. McCartney, J. D. Marks, W. F. Stafford III, L.L. Houston, J. S. Huston, and L. M. Weiner Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers Clin. Cancer Res., March 1, 2006; 12(5): 1599 - 1605. [Abstract] [Full Text] [PDF]

				T. A. Sulchek, R. W. Friddle, K. Langry, E. Y. Lau, H. Albrecht, T. V. Ratto, S. J. DeNardo, M. E. Colvin, and A. Noy Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds PNAS, November 15, 2005; 102(46): 16638 - 16643. [Abstract] [Full Text] [PDF]

				D. Berndorff, S. Borkowski, S. Sieger, A. Rother, M. Friebe, F. Viti, C. S. Hilger, J. E. Cyr, and L. M. Dinkelborg Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate Clin. Cancer Res., October 1, 2005; 11(19): 7053s - 7063s. [Abstract] [Full Text] [PDF]

				H M Brereton, S D Taylor, A Farrall, D Hocking, M A Thiel, M Tea, D J Coster, and K A Williams Influence of format on in vitro penetration of antibody fragments through porcine cornea Br. J. Ophthalmol., September 1, 2005; 89(9): 1205 - 1209. [Abstract] [Full Text] [PDF]

				C. M. Richman, S. J. DeNardo, R. T. O'Donnell, A. Yuan, S. Shen, D. S. Goldstein, J. M. Tuscano, T. Wun, H. K. Chew, P. N. Lara, et al. High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody Clin. Cancer Res., August 15, 2005; 11(16): 5920 - 5927. [Abstract] [Full Text] [PDF]

				X. Cheng, Y. Zhang, N. Kotani, T. Watanabe, S. Lee, X. Wang, I. Kawashima, T. Tai, N. Taniguchi, and K. Honke Production of a Recombinant Single-Chain Variable-Fragment (scFv) Antibody against Sulfoglycolipid J. Biochem., March 1, 2005; 137(3): 415 - 421. [Abstract] [Full Text] [PDF]

				D. E. Milenic, K. Garmestani, E. D. Brady, P. S. Albert, D. Ma, A. Abdulla, and M. W. Brechbiel Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease Clin. Cancer Res., December 1, 2004; 10(23): 7834 - 7841. [Abstract] [Full Text] [PDF]

				H. Kobayashi, K. Reijnders, S. English, A. T. Yordanov, D. E. Milenic, A. L. Sowers, D. Citrin, M. C. Krishna, T. A. Waldmann, J. B. Mitchell, et al. Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation Clin. Cancer Res., November 15, 2004; 10(22): 7712 - 7720. [Abstract] [Full Text] [PDF]

				Z. Yao, M. Zhang, K. Garmestani, D. B. Axworthy, R. W. Mallett, A. R. Fritzberg, L. J. Theodore, P. S. Plascjak, W. C. Eckelman, T. A. Waldmann, et al. Pretargeted {alpha} Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-Tetraacetic Acid-Biotin Clin. Cancer Res., May 1, 2004; 10(9): 3137 - 3146. [Abstract] [Full Text] [PDF]

				J. Liu, D. Wei, F. Qian, Y. Zhou, J. Wang, Y. Ma, and Z. Han pPIC9-Fc: A Vector System for the Production of Single-Chain Fv-Fc Fusions in Pichia pastoris as Detection Reagents In Vitro J. Biochem., December 1, 2003; 134(6): 911 - 917. [Abstract] [Full Text] [PDF]

				J. Krauss, M. A.E. Arndt, A. C.R. Martin, H. Liu, and S. M. Rybak Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment Protein Eng. Des. Sel., October 1, 2003; 16(10): 753 - 759. [Abstract] [Full Text] [PDF]

				B. Blanco, P. Holliger, R. G. Vile, and L. Alvarez-Vallina Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells J. Immunol., July 15, 2003; 171(2): 1070 - 1077. [Abstract] [Full Text] [PDF]

				K. Itoh, K. Inoue, T. Tezuka, H. Tada, Y. Hashimoto, T. Masuko, and T. Suzuki Molecular Structural and Functional Characterization of Tumor Suppressive Anti-ErbB-2 Monoclonal Antibody by Phage Display System J. Biochem., February 1, 2003; 133(2): 239 - 245. [Abstract] [Full Text] [PDF]

				H. Kobayashi, K. Shirakawa, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, I. Watanabe, Y. Heike, K. Togashi, J. Konishi, et al. Rapid Accumulation and Internalization of Radiolabeled Herceptin in an Inflammatory Breast Cancer Xenograft with Vasculogenic Mimicry Predicted by the Contrast-enhanced Dynamic MRI with the Macromolecular Contrast Agent G6-(1B4M-Gd)256 Cancer Res., February 1, 2002; 62(3): 860 - 866. [Abstract] [Full Text] [PDF]

				T. K. Bera, J. Williams-Gould, R. Beers, P. Chowdhury, and I. Pastan Bivalent Disulfide-stabilized Fragment Variable Immunotoxin Directed against Mesotheliomas and Ovarian Cancer Mol. Cancer Ther., December 1, 2001; 1(2): 79 - 84. [Abstract] [Full Text] [PDF]

				A. Goel, J. Baranowska-Kortylewicz, S. H. Hinrichs, J. Wisecarver, G. Pavlinkova, S. Augustine, D. Colcher, B. J.M. Booth, and S. K. Batra 99mTc-Labeled Divalent and Tetravalent CC49 Single-Chain Fv's: Novel Imaging Agents for Rapid In Vivo Localization of Human Colon Carcinoma J. Nucl. Med., October 1, 2001; 42(10): 1519 - 1527. [Abstract] [Full Text] [PDF]

				M. Onda, S. Nagata, Y. Tsutsumi, J. J. Vincent, Q.-c. Wang, R. J. Kreitman, B. Lee, and I. Pastan Lowering the Isoelectric Point of the Fv Portion of Recombinant Immunotoxins Leads to Decreased Nonspecific Animal Toxicity without Affecting Antitumor Activity Cancer Res., July 1, 2001; 61(13): 5070 - 5077. [Abstract] [Full Text] [PDF]

				J. F. Gestin, A. Loussouarn, M. Bardies, E. Gautherot, A. Gruaz-Guyon, C. Sai-Maurel, J. Barbet, C. Curtet, J. F. Chatal, and A. Faivre-Chauvet Two-Step Targeting of Xenografted Colon Carcinoma Using a Bispecific Antibody and 188Re-Labeled Bivalent Hapten: Biodistribution and Dosimetry Studies J. Nucl. Med., January 1, 2001; 42(1): 146 - 153. [Abstract] [Full Text] [PDF]

				A. Goel, S. Augustine, J. Baranowska-Kortylewicz, D. Colcher, B. J. M. Booth, G. Pavlinkova, M. Tempero, and S. K. Batra Single-Dose versus Fractionated Radioimmunotherapy of Human Colon Carcinoma Xenografts Using 131I-labeled Multivalent CC49 Single-chain Fvs Clin. Cancer Res., January 1, 2001; 7(1): 175 - 184. [Abstract] [Full Text]

				A. Goel, D. Colcher, J. Baranowska-Kortylewicz, S. Augustine, B. J. M. Booth, G. Pavlinkova, and S. K. Batra Genetically Engineered Tetravalent Single-Chain Fv of the Pancarcinoma Monoclonal Antibody CC49: Improved Biodistribution and Potential for Therapeutic Application Cancer Res., December 1, 2000; 60(24): 6964 - 6971. [Abstract] [Full Text]

				N. Kang, S. Hamilton, J. Odili, G. Wilson, and J. Kupsch In Vivo Targeting of Malignant Melanoma by 125Iodine- and 99mTechnetium-labeled Single-chain Fv Fragments against High Molecular Weight Melanoma-associated Antigen Clin. Cancer Res., December 1, 2000; 6(12): 4921 - 4931. [Abstract] [Full Text]

				U. B. Nielsen, G. P. Adams, L. M. Weiner, and J. D. Marks Targeting of Bivalent Anti-ErbB2 Diabody Antibody Fragments to Tumor Cells Is Independent of the Intrinsic Antibody Affinity Cancer Res., November 1, 2000; 60(22): 6434 - 6440. [Abstract] [Full Text]

				A. Schmiedl, F. Breitling, and S. Dubel Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli Protein Eng. Des. Sel., October 1, 2000; 13(10): 725 - 734. [Abstract] [Full Text] [PDF]

				D. A. Vallera, D. W. Kuroki, A. Panoskaltsis-Mortari, D. J. Buchsbaum, B. E. Rogers, and B. R. Blazar Molecular modification of a recombinant anti-CD3epsilon -directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model Blood, August 1, 2000; 96(3): 1157 - 1165. [Abstract] [Full Text] [PDF]

				A. Loffler, P. Kufer, R. Lutterbuse, F. Zettl, P. T. Daniel, J. M. Schwenkenbecher, G. Riethmuller, B. Dorken, and R. C. Bargou A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes Blood, March 15, 2000; 95(6): 2098 - 2103. [Abstract] [Full Text] [PDF]

				M W J d. Brok, G C de Gast, J H M Schellens, and J H Beijnen Targeted toxins Journal of Oncology Pharmacy Practice, December 1, 1999; 5(4): 149 - 165. [Abstract] [PDF]

				D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744. [Abstract] [Full Text] [PDF]

				M. A.E. Arndt, J. Krauss, S. M. Kipriyanov, M. Pfreundschuh, and M. Little A Bispecific Diabody That Mediates Natural Killer Cell Cytotoxicity Against Xenotransplantated Human Hodgkin's Tumors Blood, October 15, 1999; 94(8): 2562 - 2568. [Abstract] [Full Text] [PDF]

				D. COLCHER, G. PAVLINKOVA, G. BERESFORD, B. J.M. BOOTH, and S. K. BATRA Single-Chain Antibodies in Pancreatic Cancer Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 263 - 280. [Abstract] [Full Text] [PDF]

				P. Holliger, O. Manzke, M. Span, R. Hawkins, B. Fleischmann, L. Qinghua, J. Wolf, V. Diehl, O. Cochet, G. Winter, et al. Carcinoembryonic Antigen (CEA)-specific T-Cell Activation in Colon Carcinoma Induced by Anti-CD3Anti-CEA Bispecific Diabodies and B7Anti-CEA Bispecific Fusion Proteins Cancer Res., June 1, 1999; 59(12): 2909 - 2916. [Abstract] [Full Text] [PDF]

				C.-T. Kuan, C. J. Reist, C. F. Foulon, I. A. J. Lorimer, G. Archer, C. N. Pegram, I. Pastan, M. R. Zalutsky, and D. D. Bigner 125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts Clin. Cancer Res., June 1, 1999; 5(6): 1539 - 1549. [Abstract] [Full Text] [PDF]

				D. Shan, O. W. Press, T. T. Tsu, M. S. Hayden, and J. A. Ledbetter Characterization of scFv-Ig Constructs Generated from the Anti-CD20 mAb 1F5 Using Linker Peptides of Varying Lengths J. Immunol., June 1, 1999; 162(11): 6589 - 6595. [Abstract] [Full Text] [PDF]

				B. Carnemolla, P. Castellani, M. Ponassi, L. Borsi, S. Urbini, G. Nicolo, A. Dorcaratto, G. Viale, G. Winter, D. Neri, et al. Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody Am. J. Pathol., May 1, 1999; 154(5): 1345 - 1352. [Abstract] [Full Text] [PDF]

				S.-J. Liu, Y.-P. Sher, C.-C. Ting, K.-W. Liao, C.-P. Yu, and M.-H. Tao Treatment of B-Cell Lymphoma With Chimeric IgG and Single-Chain Fv Antibody-Interleukin-2 Fusion Proteins Blood, September 15, 1998; 92(6): 2103 - 2112. [Abstract] [Full Text] [PDF]

				J. De Jonge, C. Heirman, M. d. Veerman, S. Van Meirvenne, M. Moser, O. Leo, and K. Thielemans In Vivo Retargeting of T Cell Effector Function by Recombinant Bispecific Single Chain Fv (Anti-CD3 Anti-Idiotype) Induces Long-Term Survival in the Murine BCL1 Lymphoma Model J. Immunol., August 1, 1998; 161(3): 1454 - 1461. [Abstract] [Full Text] [PDF]

				F. J. Hoedemaeker, T. Signorelli, K. Johns, D. A. Kuntz, and D. R. Rose A Single Chain Fv Fragment of P-glycoprotein-specific Monoclonal Antibody C219. DESIGN, EXPRESSION, AND CRYSTAL STRUCTURE AT 2.4 A RESOLUTION J. Biol. Chem., November 21, 1997; 272(47): 29784 - 29789. [Abstract] [Full Text] [PDF]

				A. L. Lindstrom, S. L. Erlandsen, J. H. Kersey, and C. A. Pennell An In Vitro Model for Toxin-Mediated Vascular Leak Syndrome: Ricin Toxin A Chain Increases the Permeability of Human Endothelial Cell Monolayers Blood, September 15, 1997; 90(6): 2323 - 2334. [Abstract] [Full Text] [PDF]

				D. A. Berk, F. Yuan, M. Leunig, and R. K. Jain Direct in vivo measurement of targeted binding in a human tumor xenograft PNAS, March 4, 1997; 94(5): 1785 - 1790. [Abstract] [Full Text] [PDF]

				I. A. J. Lorimer, A. Keppler-Hafkemeyer, R. A. Beers, C. N. Pegram, D. D. Bigner, and I. Pastan Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: Targeting with a single chain antibody variable domain isolated by phage display PNAS, December 10, 1996; 93(25): 14815 - 14820. [Abstract] [Full Text] [PDF]

				W. D. Mallender, J. Carrero, and E. W. Voss Jr. Comparative Properties of the Single Chain Antibody and Fv Derivatives of mAb 4-4-20 J. Biol. Chem., March 8, 1996; 271(10): 5338 - 5346. [Abstract] [Full Text] [PDF]